ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03653325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03653325
Other papers using this trial's data
  • Postresuscitation oxygen reserve index-guided oxygen titration in out-of-hospital cardiac arrest survivors: A randomised controlled trial Resuscitation, 2024-01 DOI, PubMed 37863418

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03653325. Randomized; no masking; primary purpose treatment. Start 2018-11-08 (actual); primary completion 2022-01-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest
Acronym
ORI-ONE
Condition
Out-Of-Hospital Cardiac Arrest
Condition
Oxygen Toxicity
Intervention (Device)
ORI measurement
Intervention (Device)
oxygen saturation measurement
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre (class: other)
Collaborator
Centre Hospitalier Universitaire Brugmann (class: other)
Collaborator
Masimo Corporation (class: industry)

Record details

Record id
cardio:ct-nct03653325
Content hash
a103782176ae2459426e215eab2634a6e42b5ef5ce9e9d6b021a9c74ea7264a2